IMCC: מכפיל PEG IMC

IM Cannabis Corp. supplies premium medical cannabis to pharmacies across Europe and Israel. However, collapsing wholesale prices and regulatory hurdles are hindering profitability, while complex logistics chains limit margin growth. The P/E ratio relative to projected growth demonstrates the asset's value dynamics against development rates, while 0.00 captures the current state of the parameter.

The indicator calculation is based on the ratio of the current P/E multiple to the compound annual growth rate of net income. This metric determines the fair value of the asset, eliminating speculative noise and overpayment for future expectations. For IM Cannabis Corp. (IMCC), stable demand for specialized chronic pain therapy strains creates a foundation for predictable EPS growth. By analyzing the P/E relative to EPS growth rates, an investor can identify the actual undervaluation of the business. Values below one on this chart signal the potential for a sharp price impulse.